Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
PUT
Universal Health Services
UHS
$10.4B
| $161K | ﹤0.01% |
1,200
-4,600
| -79% | -$607K |
|
|
XONE
4002
CALL
DELISTED
The ExOne Company
XONE
| $161K | ﹤0.01% |
15,200
-55,400
| -78% | -$626K |
|
4003
Nektar Therapeutics
NKTR
$2.47B
| $160K | ﹤0.01% |
755
+521
| +223% | +$116K |
|
4004
PUT
Teradata
TDC
$2.47B
| $160K | ﹤0.01% |
6,400
-900
| -12% | -$23.9K |
|
4005
PUT
Vipshop
VIPS
$7.46B
| $160K | ﹤0.01% |
14,300
-59,900
| -81% | -$733K |
|
|
KCG
4006
PUT
DELISTED
KCG Holdings, Inc.
KCG
| $160K | ﹤0.01% |
12,000
+6,700
| +126% | +$88.9K |
|
|
LOCK
4007
PUT
DELISTED
LifeLock, Inc.
LOCK
| $160K | ﹤0.01% |
10,100
-11,500
| -53% | -$150K |
|
4008
PUT
Sanofi
SNY
$104B
| $159K | ﹤0.01% |
3,800
-68,600
| -95% | -$2.81M |
|
4009
Webster Financial
WBS
$12.8B
| $159K | ﹤0.01% |
4,700
+162
| +4% | +$5.9K |
|
|
XONE
4010
PUT
DELISTED
The ExOne Company
XONE
| $159K | ﹤0.01% |
15,000
-400
| -3% | -$4.52K |
|
4011
PUT
O-I Glass
OI
$1.15B
| $158K | ﹤0.01% |
8,800
-600
| -6% | -$11K |
|
|
TCF
4012
DELISTED
TCF Financial Corporation
TCF
| $158K | ﹤0.01% |
12,503
+9,571
| +326% | +$127K |
|
4013
CALL
Armstrong World Industries
AWI
$7.86B
| $157K | ﹤0.01% |
4,000
+1,600
| +67% | +$65.6K |
|
|
CY
4014
PUT
DELISTED
Cypress Semiconductor
CY
| $157K | ﹤0.01% |
14,900
+600
| +4% | +$5.72K |
|
4015
PUT
Groupon
GRPN
$1.04B
| $156K | ﹤0.01% |
2,395
-1,605
| -40% | -$119K |
|
4016
El Pollo Loco
LOCO
$503M
| $156K | ﹤0.01% |
11,938
+11,840
| +12,082% | +$147K |
|
4017
Manitowoc
MTW
$512M
| $156K | ﹤0.01% |
7,117
-31,984
| -82% | -$695K |
|
4018
PUT
Toll Brothers
TOL
$14.5B
| $156K | ﹤0.01% |
5,800
-4,400
| -43% | -$124K |
|
|
DNR
4019
PUT
DELISTED
Denbury Resources, Inc.
DNR
| $156K | ﹤0.01% |
43,400
+17,800
| +70% | +$66.9K |
|
|
STRZA
4020
CALL
DELISTED
Starz - Series A
STRZA
| $156K | ﹤0.01% |
5,200
+2,200
| +73% | +$58.6K |
|
4021
Allegiant Air
ALGT
$2.79B
| $155K | ﹤0.01% |
+1,024
| New | +$158K |
|
4022
PUT
Banco Bradesco
BBD
$37.9B
| $155K | ﹤0.01% |
38,304
-1,025
| -3% | -$3.77K |
|
|
HIMX
4023
PUT
Himax Technologies
HIMX
$2.33B
| $155K | ﹤0.01% |
18,800
+12,300
| +189% | +$121K |
|
4024
PUT
Nasdaq
NDAQ
$52.9B
| $155K | ﹤0.01% |
+7,200
| New | +$154K |
|
|
FOE
4025
DELISTED
Ferro Corporation
FOE
| $155K | ﹤0.01% |
11,600
-1,293
| -10% | -$17.1K |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.